Attenuation of tolerance to opioid-induced antinociception by idazoxan and other I2-ligands

被引：13

作者：

Boronat, MA ^{[1
]}

Olmos, G ^{[1
]}

García-Sevilla, JA ^{[1
]}

机构：

[1] Univ Balearic Isl, Dept Biol, CSIC,Lab Neuropharmacol, Inst Neurobiol Ramon & Cajal,Associate Unit, E-07071 Palma de Mallorca, Spain

来源：

IMIDAZOLINE RECEPTORS AND THEIR ENDOGENOUS LIGANDS: CURRENT CONCEPTS AND THERAPEUTIC POTENTIAL | 1999年 / 881卷

关键词：

D O I：

10.1111/j.1749-6632.1999.tb09380.x

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：359 / 363

页数：5

共 18 条

[1] LSL-60101, A SELECTIVE LIGAND FOR IMIDAZOLINE I-2 RECEPTORS, ON GLIAL FIBRILLARY ACIDIC PROTEIN-CONCENTRATION
ALEMANY, R
OLMOS, G
ESCRIBA, PV
MENARGUES, A
OBACH, R
GARCIASEVILLA, JA
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 280 (02) : 205 - 210
[2] BEITNERJOHNSON D, 1992, J NEUROSCI, V12, P2165
[3] Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands
Boronat, MA
Olmos, G
García-Sevilla, JA
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (01) : 175 - 185
[4] THE PHARMACOLOGY OF RS-15385-197, A POTENT AND SELECTIVE ALPHA-2-ADRENOCEPTOR ANTAGONIST
BROWN, CM
MACKINNON, AC
REDFERN, WS
HICKS, PE
KILPATRICK, AT
SMALL, C
RAMCHARAN, M
CLAGUE, RU
CLARK, RD
MACFARLANE, CB
SPEDDING, M
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (02) : 516 - 525
[5] D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74
[6] Marked decrease of immunolabelled 68 kDa neurofilament (NF-L) proteins in brains of opiate addicts
GarciaSevilla, JA
Ventayol, P
Busquets, X
LaHarpe, R
Walzer, C
Guimon, J
[J]. NEUROREPORT, 1997, 8 (07) : 1561 - 1565
[7] Gilad Gad M., 1996, Life Sciences, V58, pPL41
[8] GUERREROMUNOZ F, 1979, J PHARMACOL EXP THER, V209, P132
[9] HERMAN BH, 1995, NEUROPSYCHOPHARMACOL, V13, P269, DOI 10.1016/0893-133X(95)00140-9
[10] Modulation of opioid analgesia by agmatine
Kolesnikov, Y
Jain, S
Pasternak, GW
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 296 (01) : 17 - 22